 |
| Future of Your Baby! |
Non-Invasive parental testing for Chromosomal Abnormalities (NIPT) was pioneered by Laboratories in USA/Europe in 2011 and since then several hundred thousand women across the world have avoided potentially unnecessary invasive procedures while still gaining important information about the health of their pregnancies recent scientific advancements in this field have helped NIPT to be available to even more pregnant women looking for relevant genetic and chromosomal information about their pregnancy.
Visibility is a laboratory test developed by Sequenom laboratories USA and is useful for those Pregnant women who want more information about common foetal trisomies and the patient population that would benefit include those who.
- Have single Gestational pregnancies and are considered to be average risk based on the Ultrasound and Nuchal Translucency reports at week 10 to 12 of pregnancy.
- Desire High Accuracy for Trisomy 21(Down's Syndrome) and Trisomy 18 (Edwards Syndrome).
- Pregnant women having history of Down's Syndrome. The Visibility test was designed to mirror the common foetal Trisomies provided by current Serum Screening tests which are commonly done at week 10 to 12 of pregnancy.
ADVANTAGES
- It provides individualized risk assessment of Trisomy 18 and Trisomy 21.
- High Risk Results indicated >1/100 chance of Trisomy.
- Very Low false positive rates <1.5% non reportable rates in laboratory testing.
